Pioglitazone produces rapid and persistent reduction of vascular inflammation in patients with hypertension and type 2 diabetes mellitus who are receiving angiotensin II receptor blockers

✍ Scribed by Hiroyuki Takase; Ai Nakazawa; Sumiyo Yamashita; Takayuki Toriyama; Koichi Sato; Ryuzo Ueda; Yasuaki Dohi

• Book ID: 119325591
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 154 KB
• Volume: 56
• Category: Article
• ISSN: 1532-8600
• DOI: 10.1016/j.metabol.2007.01.002